PT Mitra Keluarga Karyasehat Tbk, (MIKA) Fair Value & Analysis
Healthcare · ID · Market cap 23.7T IDR
Fair value as of: Jul 12, 2026
From 26 valuation models · updated 28 days ago
Fair value updated Jul 12, 2026, revised from 2,095 IDR to 2,143 IDR (+2.3%) since Jun 24, 2026. Share price +11.2% over the past month.
A solid business, screening 13% undervalued on our models.
What matters now
- A fairly wide model range (1,292 IDR to 2,699 IDR) leaves room in how you read the outcome.
- Our model range runs from 1,292 IDR (bear) to 2,699 IDR (bull), base 2,143 IDR. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 71/100 (solid quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range 1,396 IDR – 3,128 IDR · fair‑value band 1,292 IDR – 2,699 IDR · the 1,890 IDR price screens below the 2,143 IDR fair value. Dashed = 300-day average. As of Jul 12, 2026.
Analysis
PT Mitra Keluarga Karyasehat Tbk, (MIKA) currently trades at 1,890 IDR, while our model-based Fair Value estimate is 2,143 IDR, implying the stock looks roughly 13.4% undervalued today. The Quality Score stands at 71/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, PT Mitra Keluarga Karyasehat Tbk, generated revenue of 5.5T IDR at a net margin of 25.3%. Revenue grew 6.6% year over year. It earns a return on equity of 18.0%. The balance sheet holds a net cash position of 2.5T IDR. Fundamentals as of Jul 12, 2026
Our scenario range runs from 1,292 IDR (bear case) to 2,699 IDR (bull case); at 1,890 IDR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 32% below its 52-week high and 35% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 13%, MIKA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (1,756 IDR) versus Asset-Based (349.52 IDR). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 70 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services. Its hospital network comprises Mitra Keluarga Hospitals and Kasih Group Hospitals located in Greater Jakarta, West Java, East Java, and Central Java.
Full company description
PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services. Its hospital network comprises Mitra Keluarga Hospitals and Kasih Group Hospitals located in Greater Jakarta, West Java, East Java, and Central Java. The company was founded in 1989 and is headquartered in Jakarta, Indonesia. PT Mitra Keluarga Karyasehat Tbk is a subsidiary of PT Griyainsani Cakrasadaya.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Mitra Keluarga Karyasehat Tbk, reported revenue of 5.4T IDR in FY2025 versus 4.4T IDR in FY2021, a compound +5.4%/yr. Reported net income was 1.4T IDR in FY2025, compounding +2.7%/yr from FY2021.
Watch MIKA: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare PT Mitra Keluarga Karyasehat Tbk, with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is PT Mitra Keluarga Karyasehat Tbk, (MIKA) overvalued or undervalued?
What is the fair value of MIKA?
What is the quality score of MIKA?
What is the revenue of PT Mitra Keluarga Karyasehat Tbk, (MIKA)?
What is the net profit margin of MIKA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Mitra Keluarga Karyasehat Tbk, and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.